Sclerostin-silenced human umbilical cord mesenchymal stem cells ameliorate bone metabolism in steroid-induced femoral head necrosis

doi:10.4252/wjsc.v17.i10.110190

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 10

This Article

(52)

(75)

(0)

(18)

(1)

(825)

(5)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Stem Cells. Oct 26, 2025; 17(10): 110190
Published online Oct 26, 2025. doi: 10.4252/wjsc.v17.i10.110190

Full Size Figure Download Figure

Figure 1 Sequencing of sclerostin gene silencing dinucleotide chain target sequence after insertion into pLEX (lentiviral expression)-short hairpin RNA-1 plasmid.

Citation: Lv H, Zheng CF, Chen XY, Wei JH, Tao YZ, Feng L, Feng Z, Lu SJ. Sclerostin-silenced human umbilical cord mesenchymal stem cells ameliorate bone metabolism in steroid-induced femoral head necrosis. World J Stem Cells 2025; 17(10): 110190
URL: https://www.wjgnet.com/1948-0210/full/v17/i10/110190.htm
DOI: https://dx.doi.org/10.4252/wjsc.v17.i10.110190

Lv H, Zheng CF, Chen XY, Wei JH, Tao YZ, Feng L, Feng Z, Lu SJ. Sclerostin-silenced human umbilical cord mesenchymal stem cells ameliorate bone metabolism in steroid-induced femoral head necrosis. World J Stem Cells 2025; 17(10): 110190 [PMID: 41180213 DOI: 10.4252/wjsc.v17.i10.110190]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.